European Equities Recover, Pharma Sector Takes the Lead
2025-10-01 09:29
By
Joana Taborda
1 min. read
The STOXX 50 hovered near the flatline on Wednesday, while the STOXX 600 advanced 0.4%, attempting to start Q4 on firmer footing after a soft opening.
Pharmaceuticals led gains, with Novo Nordisk (+3.7%), Novartis (+2.4%), AstraZeneca (+6.2%), Roche (+5.1%), and Sanofi (+4.1%) rallying on investor relief over tariffs.
The move followed an agreement between Pfizer and the Trump administration allowing patients to purchase discounted prescription drugs through a new federal website.
Still, broader sentiment was capped by concerns over the ongoing US government shutdown.
Banks underperformed, with Unicredit (-1%), Intesa Sanpaolo (-0.6%), BNP Paribas (-0.3%), BBVA (-1%), and Sabadell (-1%) trading lower after a Mexican board member of Sabadell accepted BBVA’s takeover bid.
On the data front, Eurozone inflation edged up to 2.2% in September, in line with expectations, reinforcing the ECB’s cautious stance on further rate cuts.